(OTC: KKUR) to Begin Testing Its 100% Accurate Cancer Detection System
May 18 2010 - 7:30AM
Marketwired
ChromoCure, Inc. (PINKSHEETS: KKUR) announced that it will begin
clinical trials on its 100% accurate and effective cancer detection
system on standard "Pap Smears" to test for cervical cancer
(http://finance.yahoo.com/news/ChromoCure-Genome-Research-iw-679357101.html?x=0&.v=1).
ChromoCure's claim that it can detect cancer 100% of the time
effectively via the "aneuploidy method," has been backed by the
Mayo Clinic in a December 2009 article
(http://www.mayoclinic.org/news2009-rst/5533.html).
Clinical Trial Phase 1, expected to be finished by April 15th
2011, should enhance the company's ability to apply and be approved
for usage in Europe.
For more information, please visit www.chromocure.com.
Other active stocks are Beckman Coulter Inc. (NYSE: BEC),
Cepheid (NASDAQ: CPHD) and Abbott Laboratories (NYSE: ABT).
Information, opinions and analysis contained herein are based on
sources believed to be reliable, but no representation, expressed
or implied, is made as to its accuracy, completeness or
correctness. The opinions contained herein reflect our current
judgment and are subject to change without notice. We accept no
liability for any losses arising from an investor's reliance on or
use of this report. This report is for information purposes only,
and is neither a solicitation to buy nor an offer to sell
securities. A third party has hired and paid IO News Wire twelve
hundred and ninety five dollars for the publication and circulation
of this news release. Certain information included herein is
forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995, including, but not limited to,
statements concerning manufacturing, marketing, growth, and
expansion. Such forward-looking information involves important
risks and uncertainties that could affect actual results and cause
them to differ materially from expectations expressed herein. We
have no ownership of equity, no representation; do no trading of
any kind and send no faxes or emails.
Contact: Eric Jensen www.ionewswire.com 516.942.4910
Chromocure (CE) (USOTC:KKUR)
Historical Stock Chart
From Jul 2024 to Aug 2024
Chromocure (CE) (USOTC:KKUR)
Historical Stock Chart
From Aug 2023 to Aug 2024